Home › Funds › TCG Crossover Management, LLC › MIRM

TCG Crossover Management, LLC position in MIRM

MIRUM PHARMACEUTICALS INC · Health Care

TCG Crossover Management, LLC reported holding 1,062,049 shares of MIRM (MIRUM PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$124.3M, representing 2.99% of its reported portfolio and ranking #8 among its reported holdings. TCG Crossover Management, LLC has disclosed MIRM holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)1.06M sh
Reported value held$124.33M
Portfolio Weight2.99%
First reportedQ4 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How TCG Crossover Management, LLC's MIRM position evolved

TCG Crossover Management, LLC first disclosed a stake in MIRM in Q4 2025 at 62,049 shares (US$4.9M). The position peaked in Q2 2026 at 1,062,049 shares, worth US$124.3M. Across 3 filings, TCG Crossover Management, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 1,062,049 shares valued at US$124.3M. Notable position changes include a 1612% increase in Q1 2026 (shares rose 27% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 62.05K $4.90M New
Q1 2026 1.06M $98.11M Add
Q2 2026 1.06M $124.33M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MIRM and 13F data

MIRM (MIRUM PHARMACEUTICALS INC) is a Health Care company. 61 other funds we track also report a position in MIRM — the largest reported positions include Frazier Life Sciences Management, L.P. (US$899.1M), EVENTIDE ASSET MANAGEMENT, LLC (US$146.2M), TANG CAPITAL MANAGEMENT LLC (US$144.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MIRM

All MIRM fund holders →

FAQ

How long has TCG Crossover Management, LLC held MIRM?

TCG Crossover Management, LLC has disclosed MIRM holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is TCG Crossover Management, LLC's current position in MIRM?

As of Q2 2026, TCG Crossover Management, LLC holds 1.06M shares of MIRM (MIRUM PHARMACEUTICALS INC), valued at $124.33M, representing 2.99% of its reported portfolio and ranking #8.

Has TCG Crossover Management, LLC been buying or selling MIRM?

In the latest 13F filing (Q2 2026), TCG Crossover Management, LLC held unchanged its position in MIRM. The position peaked in Q2 2026 at 1.06M shares.

Which other funds hold MIRM?

Other major institutional holders of MIRM include Frazier Life Sciences Management, L.P., EVENTIDE ASSET MANAGEMENT, LLC, TANG CAPITAL MANAGEMENT LLC, among 61 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.